Warrants (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 20, 2023 |
May 08, 2023 |
Mar. 08, 2023 |
Feb. 28, 2023 |
Jan. 31, 2023 |
May 31, 2022 |
Aug. 24, 2016 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Warrants (Details) [Line Items] | |||||||||||||
| Purchase of shares | 1,271,187 | 754,670 | 944,670 | 7,920 | 7,920 | 73,048 | 944,670 | ||||||
| IPO percentage | 75.00% | 37.50% | |||||||||||
| Private holding percenatge | 62.50% | ||||||||||||
| Volatility percentage | 57.00% | 58.00% | |||||||||||
| Risk-free rate, percentage | 0.97% | ||||||||||||
| Expected term | 3 years 219 days | 146 days | |||||||||||
| IPO scenario term | 3 years | ||||||||||||
| Underlying common stock price | $ 0.477 | ||||||||||||
| Risk free rate, percentage | 4.11% | ||||||||||||
| Other financial expenses (income) | $ 1,049 | $ 1,031,000 | |||||||||||
| Other expense (income) | $ 1,330,000 | $ 47,000 | $ 1,726,000 | $ 1,068,000 | |||||||||
| Series B Preferred Stock [Member] | |||||||||||||
| Warrants (Details) [Line Items] | |||||||||||||
| Exercise price per share | $ 10.2672 | ||||||||||||
| Purchase shares | 7,305 | ||||||||||||
| Previously Reported [Member] | Series B Preferred Stock [Member] | |||||||||||||
| Warrants (Details) [Line Items] | |||||||||||||
| Exercise price per share | $ 1.02672 | ||||||||||||
| X | ||||||||||
- Definition An IPO valuation is the process by which an analyst determines the fair value of a company's shares. Two identical companies may have very different IPO valuations simply because of the timing of the IPO and market demand. No definition available.
|
| X | ||||||||||
- Definition IPO scenario expected term. No definition available.
|
| X | ||||||||||
- Definition The amount of other financial expenses (income). No definition available.
|
| X | ||||||||||
- Definition Private holding percenatge. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Risk-free rate percentage. No definition available.
|
| X | ||||||||||
- Definition Underlying common stock price. No definition available.
|
| X | ||||||||||
- Definition Volatility percentage. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) that is infrequent in occurrence or unusual in nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|